Standout Papers

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma 2016 2026 2019 2022 1.0k
  1. Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma (2016)
    Antonio Palumbo, Asher Chanan‐Khan et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 52 standout
Sub-graph 1 of 23

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
4 intermediate papers

Works of Yeung‐Chul Mun being referenced

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
2016 Standout
Efficacy Of Ruxolitinib In Korean Myelofibrosis Patients and Cases Complicated TB Lymphadenitis During The Treatment
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Yeung‐Chul Mun 1487 1197 490 1026 149 2.8k
Jae Hoon Lee 1106 1000 541 829 161 2.3k
Daniela Damiani 1209 1103 557 824 134 2.9k
J. Thaler 1130 1088 503 965 123 4.0k
Peter Mollee 811 909 432 952 176 2.4k
Andrzej Hellmann 1956 1127 802 1104 129 3.9k
Yago Nieto 1817 1694 623 842 236 3.9k
B. Grosbois 1194 629 764 1303 116 2.6k
Frédéric Maloisel 1510 862 612 834 70 2.7k
Dianne Pulte 1333 1394 557 988 87 3.4k
Dennis Cooper 927 1075 251 451 111 2.7k

All Works

Loading papers...

Rankless by CCL
2026